Global Renal Disease Market - Industry Trends and Forecast to 2029

Renal disorder is a type of chronic condition which is affecting the functions of the kidney over a time. It is caused by numerous factors such as autoimmune disorders, genetic factors, infection in other parts of the body and sclerotic diseases.  

View Report: https://www.databridgemarketresearch.com/reports/global-renal-disease-market

Data Bridge Market Research analyses a growth rate in the global renal disease market in the forecast period 2022-2029. The expected CAGR of global renal disease market is tend to be around 5.50% in the mentioned forecast period. The market was valued at USD 96.72 billion in 2021, and it would grow up to USD 148.43 billion by 2029

Global Renal Disease Market Dynamics

Opportunities

Increased Technological Advancements

The growing occurrence of renal failure in developing countries has driven the launch of technologically advanced products in the market. For instance, in February 2014, the U.S. FDA approved the first human clinical trials of blood purification technologies for designing Wearable Artificial Kidney 2.0. This innovation is envisioned to obtain satisfactory and effective results from kidney failure patients. Therefore, technological advancement in the treatment of renal diseases such as renal failure is another factor expediting the market growth.

Drivers

Increased Incidence of Kidney Diseases

The rising prevalence of chronic kidney disease worldwide is majorly responsible for boosting the growth of the global renal drugs market. According to the National Kidney Foundation reports, approximately 10% of the global population is affected by chronic kidney disease (CKD). As per WHO facts 2019, about 1.13 billion people worldwide have hypertension. In the year 2014-2016, diabetes and hypertension were responsible for approximately 75% of kidney failure. Thus, it boosts the market growth.

Key players operating in the global renal disease market include:

Pfizer Inc (U.S.)

AstraZeneca (U.K.)

Bristol-Myers Squibb Company (U.S.)

Allergan,Inc (U.S.)

Dr. Reddy's Laboratories Ltd (India)

Endo International plc (Ireland)

Teva Pharmaceutical Industries Ltd (Israel)

Sun Pharmaceutical Industries Ltd (India)

Mylan N.V. (U.S.)

Novartis AG (Switzerland)

Global Renal Disease Market Scope

The global renal disease market is segmented on the basis of indication, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

Acute Kidney Injury

Chronic Kidney Disease

End-Stage Renal Disease

Others

Treatment

Corticosteroids

ACE Inhibitors

Diuretics

Immunosuppressive Therapy

Others

Europe has been witnessing a highest growth for global renal disease market throughout the forecasted period due to the high diagnostic rate and presence of key players in this region.

North America dominates the market due to the growing cases of kidney disorder and the presence of advanced medical facilities in order to maximize the treatment effectiveness for patient suffering from glomerular disease.

Explore More Reports:

https://databridgemarketresearchreports.blogspot.com/2024/07/automotive-ambient-lighting-market-to_22.html

https://databridgemarketresearchreports.blogspot.com/2024/07/ceramic-balls-market-to-grow-at-cagr-of.html

https://databridgemarketresearchreports.blogspot.com/2024/07/electric-toothbrush-market-to-reach-at.html

https://databridgemarketresearchreports.blogspot.com/2024/07/quick-service-restaurant-information.html

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -

Data Bridge Market Research

US: +1 614 591 3140

United Kingdom: +44 845 154 9652

APAC: +653 1251 975

Email: - sopan.gedam@databridgemarketresearch.com

This release was published on openPR.